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PIN2 Johnson & Johnson Pharmaceutical Services LLC, Raritan, NJ, USA
PIN3 Abbott Laboratories, Abbott Park, IL, USA
PIN4 Meda Pharmaceuticals Sp. z o.o., Warsaw, Poland
PIN5 GlaxoSmithKline BV, Zeist, The Netherlands
PIN6 None
PIN7 Johnson & Johnson, Raritan, NJ, USA
PIN8 GlaxoSmithKline, Mississauga, ON, Canada
PIN9 Novartis Farmaceutica Mexico, Mexico City, Mexico
PIN10 Laboratorios Dr Esteve SA, Barcelona, Spain
PIN11 None
PIN12 Pﬁzer Spain, MADRID, Spain
PIN13 glaxosmithkline, Verona, Italy
PIN14 None
PIN15 Pﬁzer Denmark, Ballerup, Denmark
PIN16 Wyeth México, Naucalpan, Mexico
PIN17 GSK, Rixensart, Belgium
PIN18 GSK, Rixensart, Belgium
PIN19 Bristol Myers Squibb China, Shanghai, China
PIN20 MedImmune, Gaithersburg, MD, USA
PIN21 None
PIN22 Gilead Sciences, Lisboa, Portugal
PIN23 Abbott Laboratories, Abbott park, IL, Afghanistan
PIN24 GlaxoSmithKline GmbH & Co. KG, Munich, Germany
PIN26 None
PIN27 None
PIN28 Roche México, Mexico City, Mexico
PIN29 Pﬁzer, MADRID, Spain
PIN30 None
PIN31 Novartis China, Beijing, China
PIN32 GlaxoSmithKline, Dublin, Ireland
PIN33 GlaxoSmithKline, Mississauga, ON, Canada
PIN34 GlaxoSmithKline Commercial, Warsaw, Poland
PIN35 Wyeth Hellas, Athens, Greece
PIN36 None
PIN37 Schering-Plough Pty Limited, North Ryde, Australia
PIN38 Abbott Korea, Seoul, South Korea
PIN39 GSK Biologicals, Rixensart, Belgium
PIN40 Janssen Cilag, Mexico, Mexico
PIN41 Novartis Farmaceutica Mexico, Mexico City, Mexico
PIN42 Wyeth Pharma GmbH, Muenster, Germany
PIN43 Wyeth Canada, Markham, ON, Canada
PIN44 Astellas Pharma Europe Ltd., Staines, UK
PIN45 GlaxoSmithKline, Zeist, The Netherlands
PIN46 Meda Pharmaceuticals Sp. z o.o., Warsaw, Poland
PIN47 GlaxoSimthKline, Madrid, Spain
PIN48 Tibotec BVBA, Mechelen, Belgium
PIN49 Novartis Vaccines and Diagnostics Italia, Siena, Italy
PIN50 Astellas Pharma GmbH, Munich, Germany
PIN51 Novartis Farmaceutica Mexico, Mexico City, Mexico
PIN52 Ministry of Health, São Paulo, Brazil; Ministry of Science and Technology, 
São Paulo, Brazil
PIN53 Roche Products Ltd., Welwyn Garden City, UK
PIN54 Wyeth Pharmaceuticals, Maidenhead, UK
PIN55 Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Madrid, 
Spain
PIN56 BMS Iberia, Madrid, Spain
PIN57 Wyeth Pharmaceuticals, Maidenhead, UK
PIN58 Janssen-Cilag, Birkeöd, Denmark
PIN59 None
PIN60 Shanghai Roche, Shanghai, China
PIN61 GlaxoSmithKline, Tokyo, Japan
PIN62 None
PIN63 GlaxoSmithKline GmbH & Co. KG, Munich, Germany
PIN64 Laboratorios Dr Esteve SA, Barcelona, Spain
PIN65 Janssen-Cilag GmbH, Neuss, Germany
PIN66 GlaxoSmithKline, Research Triangle Park, NC, USA
PIN67 Johnson & Johnson Pharmaceutical Services LLC, Raritan, NJ, USA
PIN68 Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 
Raritan, NJ, USA
PIN69 None
PIN70 sanoﬁ pasteur, lyon, France
PIN71 Sanoﬁ Aventis, Paris, France
PIN72 None
PIN73 AstraZeneca, Luton, UK
PIN74 None




PIN79 Instituto de Salut Carlos III, Madrid, Spain
PIN80 None
PIN81 None
PIN82 GlaxoSmithKline Spa, Verona, Italy
PMC1 None
PMC2 Lilly Spain, Madrid, Spain
PMC3 Centre for Pharmacotherapy Development, Helsinki, Finland
PMC4 None
PMC5 GlaxoSmithKline, Munich, Germany
PMC6 None
PMC7 None
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PMC13 State Committee for Scientiﬁc Research, Warsaw, Poland
PMC14 None
PMC15 Roche, Neuilly sur Seine, France
PMC16 None





PMC22 Lundbeck SAS, Paris, France
PMC23 None
PMC24 Walker Economics, Kingston, ON, Canada
PMC25 Allergan Inc., Irvine, CA, USA
PMC26 Thomson Reuters, Cambridge, MA, USA
PMC27 Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, 
Canada
PMC28 Pﬁzer Korea, Seoul, South Korea
PMC29 RQRUM, Montreal, QC, Canada
PMC30 Sanoﬁ-Aventis Deutschland GmbH, Berlin, Germany
PMC31 TI Pharma, Leiden, The Netherlands
PMC32 None
PMC33 Boehringer Ingelheim Limited, Bracknell, UK
PMC34 Wyeth Research, Collegeville, PA, USA
PMC35 Genome Canada, Montreal, QC, Canada; Genome Quebec, Montreal, QC, 
Canada; IRSC, Ottawa, ON, Canada
PMC36 None
PMC37 None
PMC38 EpiCept Corporation, Tarrytown, NY, USA
PMC39 Bristol-Myers Squibb, Wallingford, CT, USA
PMC40 GlaxoSmithKline Biologicals, Rixensart, Belgium
PMC41 None
PMC42 None
PMC43 Fondo de Investigación Sanitaria (FIS), Madrid, Spain
PMC44 None
PMC45 None
PMC46 HIQA, Dublin, Ireland
PMC47 None
PMC48 National Science Council, Taipei, Taiwan
PMC49 None
PMC50 None
PMC51 ICON Clinical Research, North Wales, PA, USA
PMC52 None







PMC60 Pﬁzer, Seoul, South Korea
PMC61 Boehringer Ingelheim, Ingelheim, Germany
PMC62 UCB, Brussels, Belgium
PMC63 None
PMC64 None
PMC65 Oxford Outcomes, Oxford, UK
PMC66 None
PMC67 None




PMC72 REGISTRAT-MAPI, LYON, France
PMC73 None
PMC74 Roche, Neuilly sur Seine, France
PMC75 None
PMC76 PAREXEL International, Uxbridge, UK
PMH1 None
PMH2 Pﬁzer Germany GmbH, Berlin, Germany
PMH3 Eli Lilly, London, UK
PMH4 Pﬁzer Limited, Tadworth, UK
PMH5 None
PMH6 Eli Lilly and Company, Indianapolis, IN, USA
PMH7 AstraZeneca.com, Luton, UK
PMH8 Eli Lilly, Warsaw, Poland
PMH9 AstraZeneca, Luton, UK
PMH10 Ghent University, Ghent, Belgium
PMH11 Lilly Deutschland GmbH, Bad Homburg, Germany
PMH12 CREATIV-CEUTICAL, PARIS, France
PMH13 Shire Development Inc, Wayne, PA, USA
PMH14 National Research Foundation (NRF), Pretoria, South Africa
PMH15 Eli Lilly and Company, Indianapolis, IN, USA
PMH16 CREATIV-CEUTICAL, PARIS, France
PMH17 None
PMH18 Genome Quebec, Montreal, QC, Canada; Genome Canada, Montreal, QC, 
Canada; IRSC, Ottawa, ON, Canada
PMH19 None
PMH20 Lilly Deutschland GmbH, Bad Homburg, Germany
PMH21 Eli Lilly, Warsaw, Poland
PMH22 None
PMH23 European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 
Portugal
PMH24 Lundbeck SAS, Paris, France
PMH25 Eli Lilly and Company, Surrey, UK
PMH26 Pﬁzer Inc, New York, NY, USA
PMH27 Instituto de Salud Carlos III, Madrid, Spain
PMH28 Eli Lilly and Company, Indianapolis, IN, USA
PMH29 Eli Lilly and Company, Indianapolis, IN, USA
PMH30 None
PMH31 None
PMH32 CREATIV-CEUTICAL, PARIS, France
PMH33 AstraZeneca Farmacéutica Spain S.A., Madrid, Spain
PMH34 None
PMH35 Shire Development Inc., Wayne, PA, USA
PMH36 AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA
PMH37 Pﬁzere Spain, Madrid, Spain
PMH38 Pﬁzere Spain, Madrid, Spain
PMH39 Pﬁzere Spain, Madrid, Spain
PMH40 None
PMH41 None
PMH42 Eli Lilly, London, UK
PMH43 AstraZeneca, Istanbul, Turkey
PMH44 Bayer Vital, Leverkusen, Germany
PMH45 Servier Finland Oy, Vantaa, Finland
PMH46 FNHE Management, Enugu, Nigeria
PMH47 Pﬁzer, New York, NY, USA
PMH48 AstraZeneca UK Ltd, Luton, UK




PMH53 The Ministry of Health, Labour and Welfare, Tokyo, Japan
PMH54 Shire Development Inc., Wayne, PA, USA
PMH55 None
PMH56 AstraZeneca, Stockholm, Sweden
PMH57 Lilly, S.A., Alcobendas, Spain
PMH58 AstraZeneca, Södertälje, Sweden
PMH59 Pﬁzere Spain, Madrid, Spain
PMH60 Janssen Cilag, Neuss, Germany
PMH61 Janssen-Cilag GmbH, Neuss, Germany
PMH62 AstraZeneca, Madrid, Spain
PMH63 AstraZeneca Farmacéutica Spain S.A., Madrid, Spain
PMH64 None
PMH65 Lilly, S.A., Alcobendas, Spain
PMH66 Eli Lilly and Company, Indianapolis, IN, USA
PMH67 Corvinus University of Budapest, Budapest, Hungary
PMH68 None
PMH70 Eli Lilly and Company, Indianapolis, IN, USA
PMH71 None
PMH72 National Science Council, Taipei, Taiwan
PMH73 National Research Foundation (NRF), Pretoria, South Africa; Nelson 
Mandela Metropolitan University (NMMU), Port Elizabeth, South Africa
PMH74 None
PMH75 Eli Lilly and Company, Indianapolis, IN, USA
PMH76 Eli Lilly and Company, Indianapolis, IN, USA
PMS1 Savient Pharmaceuticals, East Brunswiick, NJ, USA
PMS2 Sanoﬁ-Aventis Sp. z o.o., Warszawa, Poland
PMS3 Eli Lilly and company, Suresnes, France
PMS4 Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 
Raritan, NJ, USA; Grünenthal GmbH, Aachen, Germany
PMS5 Pﬁzer Ltd, Walton-On-The-Hill, UK
PMS6 Roche, Nutley, NJ, USA
PMS7 Eli Lilly and Company, Indianapolis, IN, USA
PMS8 PFSA, Boulogne, France
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PMS10 Japanese Society for Fracture Repair, Tokyo, Japan
PMS11 Amgen Canada, Mississauga, ON, Canada
PMS12 None
PMS13 Takeda, Deerﬁeld, IL, USA
PMS14 Wyeth Lederle Spa, Rome, Italy
PMS15 Roche, Neuilly sur Seine, France
PMS16 Roche Pharmaceuticals, São Paulo, Brazil
PMS17 Sanoﬁ-Aventis, Warsaw, Poland
PMS18 None
PMS19 Roche Pharmaceuticals, São Paulo, Brazil
PMS20 Zodiac, Sao Paulo, Brazil
PMS21 Laboratoires Roche, Paris, France
PMS22 Schering-Plough, Madrid, Spain
PMS23 German Society for Muscle Disorders, Freiburg, Germany
PMS24 None
PMS25 Pierre Fabre SA, Boulogne-billancourt, France
PMS26 None
PMS27 Sanoﬁ-Aventis, Warsaw, Poland
PMS28 Pierre Fabre SA, Boulogne-billancourt, France
PMS29 Pierre Fabre SA, Boulogne-billancourt, France
PMS30 Medtronic International, Tolochenaz, Switzerland
PMS31 Wyeth Pharmaceuticals, Midrand, South Africa
PMS32 Laboratoires Roche, Paris, France
PMS33 None
PMS35 Bristol-Myers Squibb, Braine-l’Alleud, Belgium
PMS36 None
PMS37 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
PMS38 Boehringer Ingelheim España, S.A., Barcelona, Spain
PMS39 Bristol-Myers Squibb, Braine-l’Alleud, Belgium
PMS40 Bristol-Myers Squibb, Braine-l’Alleud, Belgium
PMS41 None
PMS42 Novartis Italia, Origgio (VA), Italy
PMS43 None
PMS45 Medtronic UK, Watford, UK
PMS46 None
PMS47 Nicox, Sophia Antipolis, France
PMS48 LEO Pharma, Ballerup, Denmark
PMS49 Sanoﬁ Aventis, Warszawa, Poland
PMS50 Roche Brazil, Sao Paulo, Brazil
PMS51 Roche Brazil, Sao Paulo, Brazil
PMS52 Roche Brazil, Sao Paulo, Brazil
PMS53 Grünenthal, Madrid, Spain
PMS54 F. Hoffmann-La Roche AG, Basel, Switzerland
PMS55 Paladin Labs, Montréal, QC, Canada
PMS56 Tigenix NV, Leuven, Belgium
PMS57 Medtronic Sofamor Danek, Co.,Ltd., Tokyo, Japan
PMS58 Roche Oy, Espoo, Finland
PMS59 Novartis Pharma AG, Basel, Switzerland
PMS60 ZON-MW, Den Haag, The Netherlands
PMS61 sanoﬁ-aventis, Bridgewater, NJ, USA
PMS62 Wyeth, Paris La Défense Cedex, France
PMS63 Roche Products Limited, Welwyn Garden City, UK
PMS64 PFIZER France, PARIS, France
PMS65 None
PMS66 Amgen Germany, Munich, Germany
PMS67 Eli Lilly and Company, Indianapolis, IN, USA
PMS68 Amgen Germany, Munich, Germany
PMS69 GlaxoSmithKline, Marly le Roi, France
PMS70 Servier, Suresnes, France
PMS71 Wyeth, Collegeville, PA, USA
PMS72 None
PMS73 Pierre Fabre SA, Boulogne-billancourt, France
PMS74 Pﬁzer, Inc, Tadworth, UK
PMS75 Fondo de Investigacion Sanitaria, PI06/90351, Spain
PMS76 National Institutes of Health, Bethesda, MD, USA; The Muscular Dystrophy 
Association, Tucson, AZ, USA
PMS77 Omnicare Clinical Research Ltd, Cologne, Germany
PMS78 Schering-Plough, Madrid, Spain
PMS79 None
PMS80 CIBERESP, Barcelona, Spain; FIS (PI 06/ 90351), Madrid, Spain
PMS81 Bristol-Myers Squibb, Braine-l’Alleud, Belgium
PMS82 None
PMS83 Corvinus University of Budapest, Budapest, Hungary
PMS84 UCB, Brussels, Belgium
PMS85 GlaxoSmithKline, Marly le Roi, France; Roche, Neuilly sur Seine, France
PMS86 UCB, Brussels, Belgium
PMS87 Wyeth, PARIS LA DEFENSE, France
PMS88 None
PMS89 None
PMS90 PFSA, Boulogne, France
PMS91 Amgen Germany, Munich, Germany
PMS92 Charles University, Prague, Czech Republic
PMS93 Roche (Hellas) S.A., Athens, Greece
PMS94 None
PMS95 Roche Brazil, São Paulo, Brazil
PMS96 None
PMS97 None
PMS98 Amgen, Zug, Switzerland
PMS99 PFSA, Boulogne, France
PND1 Merck-Serono, Geneva, Switzerland
PND2 None
PND3 National Science Foundation, Tehran, Iran
PND4 None
PND5 Wyeth Lederle S.p.A, Aprilia—Latina, Italy
PND6 sanoﬁ aventis, Bridgewater, NJ, USA
PND7 Schering-Plough S.A, Madrid, Spain
PND8 Merck Serono, Madrid, Spain
PND9 UCB Pharma Oy Finland, Helsinki, Finland
PND10 Medtronic, Madrid, Spain
PND11 Medtronic, Madrid, Spain
PND12 Sanoﬁ-Aventis US, Bridgewater, NJ, USA
PND13 Allergan Inc., Irvine, CA, USA
PND14 Comtetence Network Parkinson’s Disease, Marburg, Germany
PND15 Janssen Pharmaceutica NV, Beerse, Belgium
PND16 Janssen Pharmaceutica NV, Beerse, Belgium; Janssen Cilag GmbH, Neuss, 
Germany
PND17 None
PND18 COVIDIEN, WALTHAM, MA, USA
PND19 Schering Plough S.A, Madrid, Spain
PND20 Shering-Plough, Lisbon, Portugal
PND21 Teva Neuroscience, Kansas City, MO, USA
PND22 Pﬁzer AB, Sollentuna, Sweden
PND23 UCB GmbH, Monheim, Germany
PND24 Teva Neuroscience, Kansas City, MO, USA
PND25 Lundbeck SAS, Paris, France
PND26 Bayer Healthcare, Barcelona, Spain
PND27 Pﬁzer, Tadworth, UK
PND28 Merck-Serono, Geneva, Switzerland
PND29 Teva Neuroscience, Kansas City, MO, USA
PND30 Biogen Idec, Inc, Cambridge, MA, USA
PND31 Canadian Institute of Health Research, ottawa, ON, Canada
PND32 Pﬁzer Ltd, Tadworth, UK
PND33 None
PND34 sanoﬁ-aventis U.S., Bridgewater, NJ, USA
PND35 Bayer HealthCare Pharmaceuticals, Inc., Wayne, NJ, USA
PND36 Bayer HealthCare Pharmaceuticals, Inc., Wayne, NJ, USA
PND37 Bayer Schering Pharma AG, Berlin, Germany
PND38 None
PND39 Biogen-Idec, Wellesley, MA, USA
PND40 Bayer Schering Pharma AG, Berlin, Germany
PND41 Biogen-Idec, Wellesley, MA, USA
PND42 Novartis Pharma AG, Basel, Switzerland
PND43 Bayer HealthCare Pharmaceuticals, Inc., Wayne, NJ, USA
PND44 Novartis Farmaceutica SA, Barcelona, Spain
PND45 Lundbeck SAS, Paris, France
PND46 Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, 
Canada
PND47 Canadian Institutes of Health Research, Ottawa, ON, Canada
PND48 Canadian Institutes of Health Research, Ottawa, ON, Canada
PND49 National Research Foundation (NRF), Pretoria, South Africa
PP1 IQWiG, Koln, Germany
PP2 Bristol-Myers Squibb Company, Inc., Wallingford, CT, USA
PP3 Danish Enterprise and Construction Authority, Copenhagen, Denmark
PP4 Robert Wood Johnson Foundation, Princeton, NJ, USA; RTI International, 
RTP, NC, USA
PRS1 GSK Commercial Sp. z o.o., Warsaw, Poland
PRS2 Pﬁzer Poland, Warsaw, Poland
PRS3 GSK Commercial Sp. z o.o., Warsaw, Poland
PRS4 GSK Commercial Sp. z o.o., Warsaw, Poland
PRS5 None
PRS6 Novartis Horsham Research Centre, Horsham, UK
PRS7 Nycomed GmbH, Konstanz, Germany
PRS8 GlaxoSmithKline, Moscow, Russia
PRS9 Pﬁzer Denmark ApS., Ballerup, Denmark
PRS10 Pﬁzer Denmark ApS., Ballerup, Denmark
PRS11 Teva Specialty Pharmaceuticals, Kansas City, MO, USA
PRS12 GlaxoSmithKline, Prague, Czech Republic
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PRS14 None
PRS15 GlaxoSmithKline, Moscow, Russia
PRS16 Pﬁzer Corp Hong Kong Ltd, Hong Kong, China
PRS17 Agency for Healthcare Administration, Tallahassee, FL, USA
PRS18 AstraZeneca, São Paulo, Brazil
PRS19 Thai Health Promotion Foundation, Bangkok, Thailand
PRS20 Campaign for Tobacco Free Kids, Washington, DC, USA; Johns Hopkins 
Bloomberg School of Public Health, Baltimore, MD, USA
PRS21 Novartis, Vilvoorde, Belgium
PRS22 Pﬁzer S.A, Alcobendas, Spain; Boehringer Ingelheim, Sant Cugat del Valles, 
Spain
PRS23 Regional Health Insurance Medical Service, Orléans, France; STATESIA, Le 
Mans, France
PRS24 Pﬁzer Poland, Warsaw, Poland
PRS25 None
PRS26 ALK-Abelló, Hørsholm, Denmark
PRS27 Helmholtz Center Munich, Neuherberg, Germany
PRS28 Novartis Farma, Origgio (VA), Italy
PRS29 GSK, Marly Le Roi, France
PRS30 GSK, Marly Le Roi, France
PRS31 FRSQ, Montréaal, QC, Canada
PRS32 PFSA, Boulogne, France
PRS33 Forest Research Institute, Inc., Jersey City, NJ, USA
PRS34 Boehringer Ingelheim France, Paris, France
PRS35 AstraZeneca SA, Athens, Greece
PRS36 Novartis, Vilvoorde, Belgium
PRS37 Pﬁzer Denmark ApS., Ballerup, Denmark
PRS38 None
PRS39 Novartis Farmaceutica, Barcelona, Spain
PRS40 Nycomed GmbH, Konstanz, Germany
PRS41 Novartis Farmacéutica SA, Barcelona, Spain
PRS42 Novartis Farmaceutica, Barcelona, Spain
PRS43 None
PRS44 None
PRS45 National ID Program, Madrid, Spain
PRS46 AtraZeneca UK Ltd., Luton, UK
PRS47 Agency for Healthcare Administration, Tallahassee, FL, USA
PRS48 Ministry of Health, Labour and Welfare, Tokyo, Japan
PRS49 Pﬁzer, Paris, France
PR1 None
PR2 US National Cancer Institute, Bethesda, MD, USA




PR7 Skane County Council Research and Development Foundation, Kristianstad, 
Sweden; Swedish Research Council, Stockholm, Sweden; Lund Univer-
sity, Lund, Sweden
PR8 Sidaction, Paris, France
PSS1 Novastis Pharma, Rueil-Malmaison, France
PSS2 Alcon France, Rueil Malmaison, France
PSS3 Alcon France, Rueil Malmaison, France
PSS4 Meda Pharmaceuticals Sp. z o.o., Warsaw, Poland
PSS5 Alcon France, Rueil Malmaison, France
PSS6 Pﬁzer, Madrid, Spain
PSS7 None
PSS8 Mölnlycke Health Care, Erkrath, Germany
PSS9 Basilea Pharmaceuticals Iberia SL, Madrid, Spain
PSS10 Schering-Plough, Madrid, Spain
PSS11 ALCON, PUURS, Belgium
PSS12 None
PSS13 Alcon France, Rueil-Malmaison, France
PSS14 Janssen-Cilag AB, Stockholm, Sweden
PSS15 Alcon France, Rueil Malmaison, France
PSS16 None
PSS17 Pﬁzer Animal Health, Inc., New York, NY, USA
PSS18 Alcon France, Rueil Malmaison, France
PSS19 Pﬁzer Animal Health, Inc., New York, NY, USA
PSS20 Wyeth, London, UK
PSS21 ALCON, PUURS, Belgium
PSS22 Novartis Farmaceutica Mexico, Mexico City, Mexico
PSS23 Meda Pharmaceuticals Sp. z o.o., Warsaw, Poland
PSS24 Santen Pharmaceutical Co., Seoul, South Korea
PSS25 Schering Plough S.A, Madrid, Spain
PSS26 ZonMW, The Hague, The Netherlands
PSS27 Wyeth Lederle S.p.A., Aprilia—Latina, Italy
PSS28 Janssen-Ortho Inc., Toronto, ON, Canada
PSS29 Pﬁzer Canada, Montréal, QC, Canada
PSS30 PFIZER France, PARIS, France
PSS31 MINISTRY OF HEALTH, Roma, Italy
PSS32 Allergan, Inc., Irvine, CA, USA
PSS33 Schering-Plough S. A., Madrid, Spain
PSS34 PFSA, Boulogne, France
PSS35 Basilea Pharmaceuticals S.L, Madrid, Spain
PSS36 None
PSS37 Basilea Pharmaceutica International Limited, Basle, Switzerland
PSS38 Abbott, Saint-Laurent, QC, Canada
PSS39 WYETH Pharmaceuticals France, Paris La Défense, France
PSS40 None
PSS41 L’Oréal International, Paris, France
PSS42 Alcon, Puurs, Belgium
PSS43 Abbott Laboratories, Maidenhead, UK
PSY1 Eli Lilly and Company, Indianapolis, IN, USA
PSY2 Quintiles, Falls Church, VA, USA
PSY3 None
PSY4 Center for Translational Molecular Medicine (BioChip project), Eindhoven, 
The Netherlands
PSY5 Merck Serono Ltd, London, UK
PSY6 None
PSY7 Shire plc, Danderyd, Sweden
PSY8 Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 
Raritan, NJ, USA; Grünenthal GmbH, Aachen, Germany
PSY9 Eli Lilly and Company, Indianapolis, IN, USA
PSY10 Eli Lilly and Company, Indianapolis, IN, USA
PSY11 PFIZER France, PARIS, France
PSY12 Janssen Cilag Greece, Athens, Greece
PSY13 Nutricia POlska Sp. z o.o., Warsaw, Poland
PSY14 Mundipharma Y.H., Seoul, South Korea
PSY15 None
PSY16 None
PSY17 Pﬁzer, New York, NY, USA
PSY18 Pﬁzer Canada, Kirkland, QC, Canada
PSY19 Mundipharma AB, Göteborg, Sweden
PSY20 Novo Nordisk, Princeton, NJ, USA
PSY21 Novo Nordisk Region International Operations A/S, Zurich, Switzerland
PSY22 None
PSY23 None
PSY24 Pﬁzer Spain, Madrid, Spain
PSY25 Grupo Roche Syntex de Mexico, Mexico, Mexico
PSY26 Roche Romania, Bucharest, Romania
PSY27 None
PSY28 Renapharma AB, Uppsala, Sweden
PSY29 None
PSY30 Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, 
Canada
PSY31 Baxter BioScience, Westlake Village, CA, USA
PSY32 Celgene Pty Ltd, Melbourne, Australia
PSY33 Smith & Nephew Medical Limited, Hull, UK
PSY34 None
PSY35 Janssen-Cilag AB, Sollentuna, Sweden
PSY36 None
PSY37 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, 
MD, USA
PSY38 Amgen, Thousand Oaks, CA, USA
PSY39 Merck Serono, Feltham, Middlesex, UK
PSY40 None
PSY41 Amgen, Inc., Thousand Oaks, CA, USA
PSY42 Canadian Haemophilia Society, Toronto, ON, Canada
PSY43 None
PSY44 Novo Nordisk A/S, Global Development, Soborg, Denmark
PSY45 Abbott, Rungis, France
PSY46 Pﬁzer, New York, NY, USA
PSY47 Genentech,Inc, South San Francisco, CA, USA
PSY48 Janssen-Cilag, Neuss, Germany
PSY49 Genentech, Inc, South San Francisco, CA, USA
PSY50 None
PSY51 None






PSY58 sanoﬁ aventis AB, Stockholm, Sweden
PSY59 None
PUK1 Shire Pharmaceuticals, Wayne, PA, USA
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PUK3 BAP Health Outcomes Research, Oviedo, Spain
PUK4 Roche Brazil, Sao Paulo, Brazil
PUK5 Roche Brazil, Sao Paulo, Brazil
PUK7 None
PUK8 Shire Pharmaceuticals, Wayne, PA, USA
PUK9 National University of Colombia, Bogota, Colombia
PUK10 GlaxoSmithKline, Research Triangle Park, NC, USA
PUK11 Roche Polska Sp z o.o., Warsaw, Poland
PUK12 European Commission, Brussels, Belgium
PUK13 Novartis Farmaceutica SA, Barcelona, Spain
PUK14 Pﬁzer Ltd, Sandwich, UK
PUK15 Lilly France, Paris, France
PUK16 Novartis Farmaceutica SA, Barcelona, Spain
PUK17 Janssen-Cilag, Neuss, Germany
UT1 EuroQol, Rotterdam, France; Chaire ESSEC Santé, Cergy Pontoise, 
France
UT2 None
UT3 Merck, North Wales, PA, USA
UT4 EuroQol Group, Rotterdam, The Netherlands
VA1 None
VA2 Sanoﬁ Pasteur, Lyon, France
VA3 Bill and Melinda Gates Foundation, Seatttle, WA, USA
VA4 Sanoﬁ pasteur, Lyon, France
VA5 GlaxoSmithKline, Rixensart, Belgium
VA6 MedImmune, Cambridge, UK
VA7 None
VA8 None
WP1 ZonMw, The Hague, The Netherlands
WP2 None
WP3 Sanoﬁ Pasteur, Sydney, Australia
WP4 AstraZeneca Canada, Mississauga, ON, Canada
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